Maravai Historical Income Statement
| MRVI Stock | USD 3.22 0.17 5.57% |
Historical analysis of Maravai Lifesciences income statement accounts such as Total Revenue of 462.4 M can show how well Maravai Lifesciences Holdings performed in making a profits. Evaluating Maravai Lifesciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Maravai Lifesciences's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Maravai Lifesciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Maravai Lifesciences is a good buy for the upcoming year.
Maravai |
About Maravai Income Statement Analysis
Maravai Lifesciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Maravai Lifesciences shareholders. The income statement also shows Maravai investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Maravai Lifesciences Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Maravai Lifesciences generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Maravai Lifesciences Holdings minus its cost of goods sold. It is profit before Maravai Lifesciences operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Maravai Lifesciences. It is also known as Maravai Lifesciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Maravai Lifesciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Maravai Lifesciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Maravai Lifesciences Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. As of now, Maravai Lifesciences' Income Before Tax is increasing as compared to previous years. The Maravai Lifesciences' current Total Other Income Expense Net is estimated to increase to about 784.1 M, while Tax Provision is forecasted to increase to (1.8 M).
| 2022 | 2023 | 2024 | 2025 (projected) | Interest Expense | 20.4M | 45.9M | 52.8M | 33.9M | Depreciation And Amortization | 38.1M | 48.8M | 56.1M | 33.8M |
Maravai Lifesciences income statement Correlations
Click cells to compare fundamentals
Maravai Lifesciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Maravai Lifesciences income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Tax Provision | 2.9M | 61.5M | 60.8M | (1.6M) | (1.9M) | (1.8M) | |
| Net Interest Income | (30.7M) | (30.3M) | (18.1M) | (18.1M) | (20.8M) | (21.8M) | |
| Depreciation And Amortization | 25.8M | 24.8M | 38.1M | 48.8M | 56.1M | 33.8M | |
| Interest Expense | 30.7M | 30.3M | 20.4M | 45.9M | 52.8M | 33.9M | |
| Selling General Administrative | 94.2M | 100.1M | 129.3M | 150.1M | 172.6M | 103.3M | |
| Total Revenue | 284.1M | 799.2M | 883.0M | 288.9M | 332.3M | 462.4M | |
| Gross Profit | 204.4M | 658.7M | 714.0M | 140.2M | 161.2M | 153.2M | |
| Other Operating Expenses | 183.2M | 255.8M | 316.6M | 320.6M | 368.7M | 238.6M | |
| Operating Income | 67.6M | 554.6M | 574.2M | (31.6M) | (36.4M) | (34.6M) | |
| Net Income From Continuing Ops | 78.8M | 469.3M | 490.7M | 59.0M | 67.9M | 64.5M | |
| Ebit | 112.4M | 561.0M | 571.9M | 663.6M | 763.2M | 801.3M | |
| Research Development | 9.3M | 15.2M | 18.4M | 17.3M | 19.9M | 12.5M | |
| Ebitda | 138.3M | 585.8M | 610.0M | 712.4M | 819.3M | 860.2M | |
| Cost Of Revenue | 79.6M | 140.6M | 169.0M | 148.7M | 171.1M | 122.0M | |
| Total Operating Expenses | 103.5M | 115.3M | 147.6M | 171.9M | 197.6M | 116.6M | |
| Reconciled Depreciation | 25.8M | 24.8M | 38.1M | 45.8M | 52.7M | 33.2M | |
| Income Before Tax | 81.7M | 530.8M | 551.5M | 617.7M | 710.4M | 745.9M | |
| Total Other Income Expense Net | (22.1M) | (23.9M) | (22.7M) | 649.4M | 746.8M | 784.1M | |
| Net Income Applicable To Common Shares | (8.5M) | 76.9M | 182.0M | 220.2M | 253.2M | 265.9M | |
| Net Income | 76.9M | 469.3M | 490.7M | (119.0M) | (136.9M) | (130.0M) | |
| Income Tax Expense | 2.9M | 61.5M | 60.8M | 756.1M | 869.5M | 913.0M | |
| Minority Interest | 66.2M | (287.2M) | (270.5M) | (34.5M) | (31.0M) | (32.6M) |
Currently Active Assets on Macroaxis
When determining whether Maravai Lifesciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Maravai Lifesciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Maravai Lifesciences Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Maravai Lifesciences Holdings Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Maravai Lifesciences Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Maravai Lifesciences. If investors know Maravai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Maravai Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.33) | Earnings Share (1.67) | Revenue Per Share | Quarterly Revenue Growth (0.03) | Return On Assets |
The market value of Maravai Lifesciences is measured differently than its book value, which is the value of Maravai that is recorded on the company's balance sheet. Investors also form their own opinion of Maravai Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Maravai Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Maravai Lifesciences' market value can be influenced by many factors that don't directly affect Maravai Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Maravai Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Maravai Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Maravai Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.